Menu
Back to Journals » Journal of Inflammation Research » Volume 16
RETRACTED ARTICLE: miR-16-5p Regulates Ferroptosis by Targeting SLC7A11 in Adriamycin-Induced Ferroptosis in Cardiomyocytes
Authors Chen Y, Deng Y, Chen L, Huang Z, Yan Y, Huang Z
Received 16 October 2022
Accepted for publication 21 February 2023
Published 14 March 2023 Volume 2023:16 Pages 1077—1089
DOI https://doi.org/10.2147/JIR.S393646
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Ning Quan
This paper has been retracted.
Chen Y, Deng Y, Chen L, Huang Z, Yan Y, Huang Z. J Inflamm Res. 2023;16:1077–1089.
We, the Editors and Publisher of Journal of Inflammation Research, have retracted the following article.
Following publication of the article, concerns were raised about the duplication of images from Figure 5D with images from another unrelated article. Specifically,
- The images for Figure 5D, have been duplicated with the images for Figure 4G from Wang M, Li Q, Yu S, et al. Coronin 3 Promotes the Development of Oncogenic Properties in Glioma Through the Wnt/β-Catenin Signaling Pathway. Onco Targets Ther. 2020;13:6661–6673. https://doi.org/10.2147/OTT.S257001.
The authors did not respond to our queries and were unable to provide an explanation for the duplicated images or provide data for the study. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article and the authors were notified of this.
We have been informed in our decision-making by our editorial policies and COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.